Holen Sie sich die Stockscreener-App
81.02
0.31%
-0.17
Schlusskurs vom Vortag:
$81.19
Offen:
$82.02
24-Stunden-Volumen:
58,131
Relative Volume:
0.19
Marktkapitalisierung:
$1.85B
Einnahmen:
$256.28M
Nettoeinkommen (Verlust:
$62.40M
KGV:
29.85
EPS:
2.7139
Netto-Cashflow:
$79.12M
1W Leistung:
-23.48%
1M Leistung:
-21.22%
6M Leistung:
-7.79%
1J Leistung:
-12.61%
1-Tages-Spanne:
$80.62
$82.73
1-Wochen-Bereich:
$78.65
$90.28
52-Wochen-Spanne:
$78.65
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
80.99 | 2.26B | 256.28M | 62.40M | 79.12M | 2.7139 |
ISRG
Intuitive Surgical Inc
|
398.68 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.35 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
75.22 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.88 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.96 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LeMaitre Vascular (LMAT) to Announce Earnings on Tuesday - MarketBeat
First Trust group (NASDAQ: LMAT) reports 1.18M-share, 5.15% ownership position - Stock Titan
LeMaitre Vascular Inc (LMAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LeMaitre Vascular, Inc. Revenue Breakdown – NASDAQ:LMAT - TradingView
TradingKey - TradingKey
LeMaitre Vascular Inc (LMAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LeMaitre Vascular Inc (LMAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LMAT|LeMaitre Vascular Inc|Price:95.590|Chg%:-1.900 - TradingKey
LMAT|LeMaitre Vascular Inc|Price:98.920|Chg%:+3.330 - TradingKey
LMAT|LeMaitre Vascular Inc|Price:97.100|Chg%:-0.390 - TradingKey
First Trust Advisors LP Acquires 57,931 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular Inc (LMAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LeMaitre Vascular Inc (LMAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Citizens reiterates LeMaitre Vascular stock rating on growth outlook - Investing.com
Citizens reiterates LeMaitre Vascular stock rating on growth outlook By Investing.com - Investing.com Canada
LeMaitre Vascular (LMAT) Slips 1.36% as Stock Tests Key Support LevelsVolume Gap - dars.gov.et
Technical Reactions to LMAT Trends in Macro Strategies - Stock Traders Daily
Bessemer Group Inc. Boosts Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LMAT Q1 2026 Earnings: EPS Slightly Exceeds Estimates Despite Stock DeclineEPS Growth Rate - dars.gov.et
Copeland Capital Management LLC Has $95.05 Million Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LMAT6268257 Bond Risk Profile - TradingView
LMAT6268257 Bond Coupon Profile — Rate & Payments - TradingView
LMAT6268257 Bond Profile — Key Metrics - TradingView
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
LeMaitre Vascular to Report Second Quarter 2026 Financial Results on August 4 - Quiver Quantitative
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026 - The Manila Times
LeMaitre Schedules Aug. 4 Call to Discuss Second-Quarter Results - Stock Titan
LeMaitre Vascular (NASDAQ:LMAT) Cut to "Hold" at Zacks Research - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
LeMaitre Vascular Q1 2026 Earnings: EPS Slightly Beats Estimates, Stock RisesProduct Revenue Analysis - dars.gov.et
LeMaitre Vascular, Inc. $LMAT Shares Sold by Dividend Assets Capital LLC - MarketBeat
LeMaitre Vascular Inc. (LMAT) Q1 2026 Earnings: EPS Beats Estimates, Shares Climb 4%ROIC Trend Report - dars.gov.et
LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Buy" at Wall Street Zen - MarketBeat
LMAT Q1 2026 Earnings: Small EPS Beat Amid Steady PerformanceRevenue Inflection Point - dars.gov.et
LeMaitre Vascular (LMAT) Gains 4.2%: Key Technical Levels and Potential ScenariosWave Alternation - dars.gov.et
LeMaitre Vascular, Inc. $LMAT is Conestoga Capital Advisors LLC's 7th Largest Position - MarketBeat
LeMaitre Vascular, Inc. Financial Disclosures & Filings - TradingView
LMATLemaitre Vascular Inc Latest SEC Filings - Finviz
LeMaitre Vascular, Inc. $LMAT Shares Sold by SG Americas Securities LLC - MarketBeat
LMAT Technical Analysis & Stock Price Forecast - Intellectia AI
Trading the Move, Not the Narrative: (LMAT) Edition - Stock Traders Daily
Enterprise value to EBITDA forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
Price to sales forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
Price to book forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
Enterprise value to EBIT forward of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (NASDAQ:LMAT) - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (SWB:LHU) - TradingView
LeMaitre Vascular Inc (LMAT) Institutional Confidence - TradingKey
LMAT Forecast — Price Target — Prediction for 2027 - TradingView
LeMaitre Vascular, Inc. Actuals & Estimates (TRADEGATE:LHU) - TradingView
LHU Forecast — Price Target — Prediction for 2027 - TradingView
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lemaitre Vascular Inc-Aktie (LMAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LeMaitre George W | Chairman and CEO |
May 08 '26 |
Sale |
108.69 |
27,881 |
3,030,400 |
1,430,019 |
| LeMaitre George W | Chairman and CEO |
May 07 '26 |
Sale |
107.64 |
18,600 |
2,002,013 |
1,457,900 |
| Kamke Trent G | Senior V. P., Operations |
May 08 '26 |
Sale |
107.00 |
2,928 |
313,287 |
3,749 |
| Ross Bridget A | Director |
May 07 '26 |
Option Exercise |
48.15 |
5,044 |
242,882 |
8,986 |
| Ross Bridget A | Director |
May 07 '26 |
Sale |
111.10 |
5,044 |
560,366 |
3,942 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Option Exercise |
65.92 |
2,858 |
188,412 |
8,657 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Sale |
110.00 |
3,943 |
433,730 |
4,714 |
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):